dulaglutide and semaglutide Frontiers what is the difference between

Here is the concern

(PubMed) Hirahashi J

00:04:41 Vickie Danaher However, the approved and marketed products, so what were actually going to see in our pharmacies, is an orforglipron tablet with strengths ranging from 0.8 milligrams to 17.2 milligrams

Specifically watch for: Pink turning brown or amber : Could indicate oxidative degradation of the B12 or the peptide Pink turning orange : May suggest B12 degradation, particularly with light-sensitive forms like methylcobalamin Any color becoming noticeably darker : Could reflect concentration changes from solvent evaporation or chemical breakdown Color fading to clear : B12 degradation from light exposure, the medication may have lost potency Green or blue tint No normal tirzepatide formulation, whether compounded or FDA-approved, should ever appear green or blue

These effects are blunted by vagotomy and by pharmacological or genetic inactivation of the GLP-1R in vagal afferents